UPDATE: Credit Suisse Downgrades Sarepta Therapeutics (SRPT) to Neutral
Tweet Send to a Friend
(Updated - August 20, 2020 5:27 AM EDT)
(updating comment)Credit Suisse analyst Martin Auster downgraded Sarepta Therapeutics (NASDAQ: SRPT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)Credit Suisse analyst Martin Auster downgraded Sarepta Therapeutics (NASDAQ: SRPT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
